Gsk Q1 2025 Results Investor Call

Gsk Q1 2025 Results Investor Call. Glaxosmithkline pharmaceuticals ltd on friday reported a 37.87 per cent rise in consolidated net profit at rs 182.33 crore in the first quarter ended june 30, 2024. Our continued commercial success comes with a focus on driving the performance of our key growth products contributing a new record high 44% of our q1 sales, adding gbp.


Gsk Q1 2025 Results Investor Call

As a reminder, adjusted results are now referred to as core like many european pharmaceutical peers. Today’s call will last approximately 1 hour.

Gsk Q1 2025 Results Investor Call Images References :